Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ACAD — ACADIA Pharmaceuticals Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 6, 2025
REVENUE
$278.6M +5.3%
NET MARGIN
25.8% +15.7 PTS
EPS
$0.43 +168.8%
FREE CASH FLOW
$73.9M -54.5%

No summary has been written for this call yet.